Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics: Talfahrt nach FDA-Rückschlägen

TorstenPinkert 
0 0 09.09.25
Sarepta Therapeutics: Talfahrt nach FDA-Rückschlägen
 

Die Aktie von Sarepta Therapeutics zeigt sich heute mit einem leichten Plus von 1,35%…

Der Beitrag Sarepta Therapeutics: Talfahrt nach FDA-Rückschlägen erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Sarepta Therapeutics Stock

€18.35
-0.970%
The price for the Sarepta Therapeutics stock decreased slightly today. Compared to yesterday there is a change of -€0.180 (-0.970%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Sarepta Therapeutics stock is not clear.
Based on the current price of 18.35 € the target price of 135 € shows a potential of 635.9% for Sarepta Therapeutics which would more than double the current price.
Show more
Like: 0
Analystenstimmen
Share

Comments

Not a member yet? Sign up for free!